🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 4 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/11/2000 | 87,73 | 88,68 | 87,13 | 88,38 | +1,09% | 1,77% | 5.366.074 |
| 27/11/2000 | 85,70 | 88,08 | 84,98 | 87,43 | +2,45% | 3,62% | 5.621.891 |
| 24/11/2000 | 85,76 | 87,19 | 85,04 | 85,34 | -1,38% | 2,50% | 2.103.126 |
| 22/11/2000 | 86,47 | 87,61 | 84,69 | 86,53 | -1,43% | 3,38% | 7.052.621 |
| 21/11/2000 | 86,77 | 87,97 | 86,59 | 87,79 | +1,80% | 1,58% | 5.677.226 |
| 20/11/2000 | 84,03 | 86,95 | 83,97 | 86,24 | +2,12% | 3,55% | 6.451.278 |
| 17/11/2000 | 85,52 | 86,77 | 83,37 | 84,45 | -1,87% | 3,97% | 7.561.530 |
| 16/11/2000 | 87,37 | 88,14 | 85,46 | 86,06 | -1,57% | 3,07% | 4.705.730 |
| 15/11/2000 | 86,59 | 87,97 | 86,24 | 87,43 | +0,62% | 2,00% | 6.569.598 |
| 14/11/2000 | 84,63 | 87,55 | 84,27 | 86,89 | +1,89% | 3,88% | 7.472.659 |
| 13/11/2000 | 86,12 | 86,77 | 84,21 | 85,28 | -2,32% | 2,98% | 9.573.270 |
| 10/11/2000 | 85,82 | 88,50 | 85,76 | 87,31 | +1,17% | 3,20% | 6.993.409 |
| 09/11/2000 | 86,36 | 86,77 | 83,97 | 86,30 | -0,41% | 3,25% | 8.816.405 |
| 08/11/2000 | 84,92 | 87,49 | 84,92 | 86,65 | +4,53% | 3,02% | 13.156.382 |
| 07/11/2000 | 85,40 | 86,12 | 82,84 | 82,90 | -3,47% | 3,84% | 6.823.004 |
| 06/11/2000 | 82,78 | 86,36 | 82,78 | 85,88 | +2,42% | 4,32% | 7.855.808 |
| 03/11/2000 | 83,97 | 84,33 | 82,36 | 83,85 | -1,40% | 2,34% | 7.382.636 |
| 02/11/2000 | 85,10 | 85,22 | 83,85 | 85,04 | -0,70% | 1,61% | 6.716.108 |
| 01/11/2000 | 85,88 | 86,77 | 84,74 | 85,64 | -0,21% | 2,36% | 9.592.344 |
| 31/10/2000 | 84,63 | 85,88 | 83,43 | 85,82 | +1,41% | 2,89% | 9.245.770 |
| 30/10/2000 | 83,61 | 85,88 | 83,37 | 84,63 | +0,78% | 3,00% | 9.319.130 |
| 27/10/2000 | 82,00 | 83,97 | 81,70 | 83,97 | +1,51% | 2,76% | 8.859.478 |
| 26/10/2000 | 82,48 | 83,49 | 81,82 | 82,72 | -0,72% | 2,02% | 7.308.752 |
| 25/10/2000 | 81,11 | 83,37 | 80,75 | 83,31 | +2,19% | 3,24% | 8.784.860 |
| 24/10/2000 | 80,21 | 81,58 | 80,15 | 81,52 | +0,81% | 1,78% | 7.289.783 |
| 23/10/2000 | 79,44 | 81,58 | 79,08 | 80,87 | +3,51% | 3,15% | 12.235.819 |
| 20/10/2000 | 75,92 | 78,24 | 74,96 | 78,13 | +5,56% | 4,32% | 12.243.050 |
| 19/10/2000 | 73,65 | 74,31 | 72,76 | 74,01 | -0,80% | 2,11% | 5.360.101 |
| 18/10/2000 | 74,25 | 74,79 | 72,64 | 74,61 | +0,00% | 2,89% | 6.133.525 |
| 17/10/2000 | 72,46 | 74,61 | 72,46 | 74,61 | +1,71% | 2,96% | 5.605.018 |